Zevia PBC's Turnaround Narrative Shifts as Analysts Reassess the Story, Fair Value Remains Unchanged at $4.25

Analysts reassess Zevia (ZVIA) turnaround narrative, with a stable central fair value price target of $4.25 despite cautious tone and mixed execution. Telsey Advisory trimmed its price target to $5, while Goldman Sachs cut it to $3 and Morgan Stanley reduced it to $1.75. Zevia issued Q1 2026 net sales guidance of $40-$42 million and FY26 guidance of $169-$173 million.